« Previous
Next »
Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2
, Pages 153-158
, June 2008
The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer
References
- . The natural history of bladder cancer. Implications for therapy. Urol Clin North Am. 2000;27(1):1–13vii
- . Immediate adjuvant intravesical chemotherapy after transurethral resection of bladder tumour. Curr Opin Urol. 1998;8(5):407–409
- . Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS). Urol Clin North Am. 2000;27(1):15–24vii–viii
- . Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma. Urologe A. 2002;41(5):470–474
- . Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146(2):316–318
- . Serial multiple-site biopsies in patients with bladder cancer. J Urol. 1978;120(1):57–59
- . Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol. 1976;116(5):575–580
- Kappas A, Sassa S, Galbraith R, Nordmann Y. The porphyrias. In: Scriver C, Beaudet W, Sly D, Valle D, editors. New York: McGraw-Hill; 1989. p. 1305–66.
- . Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292
- . Experimental porphyric neuropathy: a preliminary report. Can J Neurol Sci. 1981;8(2):105–113
- . Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. J Photochem Photobiol B. 1986;44:679–687
- Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 1994;44(6):836–841
- . Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology. 1994;44(5):676–681
- Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology. 2001;57(4):690–694
- . Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol. 1996;155(1):105–109
- Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med. 1997;20(4):402–408
- . Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol. 1999;13(2):117–121
- . Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int. 1999;83(1):129–135
- . Fluorescence detection of bladder tumors with 5-aminolevulinic acid. J Endourol. 1999;13:755–759
- Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity. Urology. 2001;57(6):1059–1062
- . The current diagnosis of superficial bladder cancer must be reconsidered. Urol Int. 2002;69(2):85–90
- Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol. 2002;168(2):475–478
- . Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol. 2001;165(4):1121–1123
- . Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol. 2002;168(1):67–71
- Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology. 2007;69(4):675–679
- . The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21(18):1315–1330
- . Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995;33(8):828–841
- . The economic consequences of prostate and bladder cancer in the UK. BJU Int. 2005;95(1):59–63
- Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol. 2007;52(1):142–147
- . Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol. 1999;154(3):721–727
- . Fluorescence-assisted transurethral resection of bladder tumors: is it cost-effective?. Eur Urol. 2001;39(s5):1–216
PII: S1572-1000(08)00041-0
doi: 10.1016/j.pdpdt.2008.05.001
© 2008 Elsevier B.V. All rights reserved.
« Previous
Next »
Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2
, Pages 153-158
, June 2008
